Search BioPortfolio:
BioPortfolio
Web
Home
Marketing Services
News
Reports
Company Profiles
InDepth
Drug Discovery
Careers
Conferences
Videos
Search
Contact
Items Ordered:
Cart Value:
New Products:
1.
The Rise of Mid-Sized Pharma
2.
Contract Research Annual Review 2008
3.
Amgen - The Biotech Leader - Market Analyses and Outlook, 2008-2023
4.
The World OTC Pharmaceutical Market Analysis and Forecasts, 2008-2023
5.
Monoclonal Antibodies Report: 2008 Update
6.
Pipeline and Commercial Insight: Neuropathic Pain - UCB's Vimpat set to compete with major players
7.
Stakeholder Opinions: Non-hormonal Treatments for Menopausal Symptoms - Market open to takers as tepid pipeline fails to meet demand
8.
Rx-to-OTC Strategies: Maximizing the Commercial Potential of an Rx-to-OTC Switch
9.
Drug Repositioning Strategies - Serendipity by design
10.
Forecast Insight: Osteoarthritis - The COX-2 pipeline collapses
Best Sellers:
1.
BioNewsCast Press Release Distribution Service
2.
Immunogenicity to Biologics Implications of reactions against biotech drugs
3.
Outsourcing in Drug Discovery, 3rd Edition
4.
American Hospital Register
5.
Professional Designation in Biopharmaceutical Technology - 3 Course Curriculum
6.
Outlook for RNAi, 2007 - siRNA and miRNA in biology, diagnostics and therapeutics
The Bioprocessing Industry - Increasing Capacity, Production, and Efficiency, 2nd Edition
Increasing Capacity, Production, and Efficiency
By Alex D. Kanarek, Ph.D.
Published: August, 2006
Recent projections predict a serious shortfall in manufacturing capacity in the next 3 years.
The biotechnology industry has been growing at a rapid rate, currently topping $35 billion worldwide. The industry most affected by this impressive growth is the bioprocessing industry, which provides the means for the fabrication, and testing of biopharmaceutical products. The bioprocessing industry is under constant pressure to increase efficiency, reduce production costs, and speed time to market. To meet these heavy demands, bioprocessing companies are adapting and innovating faster than ever.
Scope
D&MD's Bioprocessing Industry Report presents a thorough and organized analysis of this critical industry and its major components. This Report covers the most important issues in bioprocessing including the threat of a significant shortage in manufacturing capacity, consolidation in key sectors of the industry, and the next drug discovery trends fueling expansion. In addition, more than 50 companies from various elements of the bioprocessing industry are profiled in depth.
Market Opportunities
> The competitive consumable sectors holds potential for faster growth and better profits.
> Contract services and those catering to the research and development laboratories as a large influx of R&D spending drives this industry forward.
Key Reasons to Buy
> Keep an eye on the fastest growing areas with market statistics for all major sectors of the bioprocessing industry including capital equipment and contract services.
> Understand the regulations with a thorough review of national and international rules governing bioprocessing.
> Witness the adapting industry with reports on improvements in technologies including mass cell culture, separation, purification, analytical, and final processing.
> Focus on the fastest growing sector in bioprocessing with a full chapter dedicated to the different types of contract services.
> Identify viable market opportunities with discussions of future trends and directions in bioprocessing.
> Get a unique view of industry leaders with in-depth company profiles compiled from direct contact with senior staff and industry experts.
600+ Pages - 80 Exhibits - 50+ Company Profiles
Aug-06 Pages 266
Table of Contents
Price
PDF $4,950.00
Printed $5,150.00
CD-ROM $5,150.00
Single Site Licence $6,930.00
Global Site Licence $7,425.00
Buy Biotechnology Management Reports online with BioPortfolio's secure E-Commerce portal.